Curaleaf gives back recent gains as its quarterly loss widens and it guides for 2021 revenue to be at the lower end of its range

Cannabis company reports record revenue but falls short of analyst estimates; stock falls into the red after optimism around M&A and federal legalization in the previous session quickly fades